Skip to main content

2 Result(s)

within Sara El-Sahli Remove this filter

and

  1. Article

    Open Access

    A triple-drug nanotherapy to target breast cancer cells, cancer stem cells, and tumor vasculature

    Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer, accounting for the majority of breast cancer-related death. Due to the lack of specific therapeutic targets, chemotherapeut...

    Sara El-Sahli, Khang Hua, Andrew Sulaiman, Jason Chambers, Li Li… in Cell Death & Disease (2021)

    Download PDF (1649 KB) View Article

  2. Article

    Open Access

    Co-inhibition of mTORC1, HDAC and ESR1α retards the growth of triple-negative breast cancer and suppresses cancer stem cells

    Triple-negative breast cancer (TNBC) is the most refractory subtype of breast cancer. It causes the majority of breast cancer-related deaths, which has been largely associated with the plasticity of tumor cell...

    Andrew Sulaiman, Sarah McGarry, Ka Mien Lam, Sara El-Sahli… in Cell Death & Disease (2018)

    Download PDF (2375 KB) View Article